Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cashflow Statement

COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹4,380 Cr₹2,613 Cr₹3,373 Cr₹7,344 Cr₹3,743 Cr
Adjustment ₹1,496 Cr₹1,586 Cr₹1,344 Cr₹-1,663 Cr₹1,091 Cr
Changes In working Capital ₹-1,675 Cr₹-1,095 Cr₹1,558 Cr₹-1,067 Cr₹308 Cr
Cash Flow after changes in Working Capital ₹4,201 Cr₹3,104 Cr₹6,275 Cr₹4,614 Cr₹5,142 Cr
Cash Flow from Operating Activities ₹2,435 Cr₹2,387 Cr₹5,016 Cr₹3,329 Cr₹4,381 Cr
Cash Flow from Investing Activities ₹-4,256 Cr₹-3,978 Cr₹-3,212 Cr₹599 Cr₹-1,568 Cr
Cash Flow from Financing Activities ₹800 Cr₹1,814 Cr₹-2,969 Cr₹-1,365 Cr₹-1,947 Cr
Net Cash Inflow / Outflow ₹-1,021 Cr₹223 Cr₹-1,164 Cr₹2,563 Cr₹866 Cr
Opening Cash & Cash Equivalents ₹4,392 Cr₹4,163 Cr₹5,330 Cr₹2,747 Cr₹1,876 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -₹6.41 Cr₹-3.25 Cr₹22 Cr-
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹14 Cr₹-0.06 Cr₹0.20 Cr₹-2.12 Cr₹4.78 Cr
Closing Cash & Cash Equivalent ₹3,385 Cr₹4,392 Cr₹4,163 Cr₹5,330 Cr₹2,747 Cr

Compare Cashflow Statement of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹72,059.9 Cr -0.4% 1.7% 22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.4%

1.7%

22.9%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses